J.P. Kan

434 total citations
14 papers, 355 citations indexed

About

J.P. Kan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, J.P. Kan has authored 14 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in J.P. Kan's work include Neurotransmitter Receptor Influence on Behavior (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (2 papers). J.P. Kan is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (2 papers). J.P. Kan collaborates with scholars based in France, Mexico and Italy. J.P. Kan's co-authors include M. Strolin Benedetti, P. Worms, Kathleen Bizière, Guy Chouvet, Jean‐François Pujol, J. Głowiński, F. Héry, Camille G. Wermuth, R. Roncucci and Jean Bourguignon and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

J.P. Kan

13 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Kan France 10 153 123 106 69 39 14 355
Mitsuo Egawa Japan 15 240 1.6× 191 1.6× 56 0.5× 94 1.4× 36 0.9× 34 475
F. E. SOROKO United States 11 202 1.3× 175 1.4× 204 1.9× 67 1.0× 25 0.6× 19 579
Annmarie L. Sabb United States 10 322 2.1× 260 2.1× 92 0.9× 84 1.2× 23 0.6× 14 497
Richard A. Glennon United States 8 244 1.6× 156 1.3× 54 0.5× 47 0.7× 23 0.6× 9 361
C Malcolm United Kingdom 4 333 2.2× 205 1.7× 50 0.5× 65 0.9× 23 0.6× 6 442
Kirsten L. Miller United States 10 156 1.0× 191 1.6× 59 0.6× 100 1.4× 25 0.6× 12 386
Kenneth L. Hauser United States 7 212 1.4× 239 1.9× 149 1.4× 97 1.4× 17 0.4× 9 594
Hermann J. Gerhards Germany 11 135 0.9× 126 1.0× 84 0.8× 62 0.9× 9 0.2× 18 340
Ian T. Huscroft United Kingdom 9 282 1.8× 213 1.7× 98 0.9× 59 0.9× 18 0.5× 10 442
Arvid Carlsson Sweden 11 206 1.3× 148 1.2× 65 0.6× 31 0.4× 9 0.2× 12 345

Countries citing papers authored by J.P. Kan

Since Specialization
Citations

This map shows the geographic impact of J.P. Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Kan more than expected).

Fields of papers citing papers by J.P. Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Kan. The network helps show where J.P. Kan may publish in the future.

Co-authorship network of co-authors of J.P. Kan

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Kan. A scholar is included among the top collaborators of J.P. Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Kan. J.P. Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Alonso, Richard, J.P. Kan, P. Worms, & Philippe Soubrié. (1990). Effects of repeated administration of tetrahydroaminoacridine (THA) on muscarinic receptor subtypes in the rat brain. Neurochemistry International. 17(3). 457–465. 5 indexed citations
3.
Schumacher, Cees A., R. Steinberg, J.P. Kan, et al.. (1989). Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist. European Journal of Pharmacology. 166(2). 139–147. 8 indexed citations
4.
Wermuth, Camille G., Gilbert Schlewer, Jean Bourguignon, et al.. (1989). 3-Aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activities. Journal of Medicinal Chemistry. 32(3). 528–537. 76 indexed citations
5.
Wermuth, Camille‐Georges, Gilbert Schlewer, Jean Bourguignon, et al.. (1989). ChemInform Abstract: 3‐Aminopyridazine Derivatives with Atypical Antidepressant, Serotonergic, and Dopaminergic Activities.. ChemInform. 20(32). 1 indexed citations
6.
Kan, J.P., et al.. (1987). SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.. Journal of Pharmacology and Experimental Therapeutics. 240(1). 251–258. 19 indexed citations
7.
Worms, P., J.P. Kan, Camille G. Wermuth, R. Roncucci, & Kathleen Bizière. (1987). SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.. Journal of Pharmacology and Experimental Therapeutics. 240(1). 241–250. 18 indexed citations
8.
Bizière, Kathleen, P. Worms, J.P. Kan, et al.. (1985). Minaprine, a new drug with antidepressant properties.. PubMed. 11(12). 831–40. 40 indexed citations
9.
Kan, J.P. & M. Strolin Benedetti. (1981). Characteristics of the Inhibition of Rat Brain Monoamine Oxidase In Vitro by MD780515. Journal of Neurochemistry. 36(4). 1561–1571. 29 indexed citations
10.
Kan, J.P. & M. Strolin Benedetti. (1980). Antagonism between long acting Monoamine Oxidase Inhibitors (MAOI) and MD780515, a new specific and reversible MAOI. Life Sciences. 26(25). 2165–2171. 13 indexed citations
11.
Keane, P.E., et al.. (1979). Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat. Journal of Pharmacy and Pharmacology. 31(1). 752–754. 16 indexed citations
12.
Kan, J.P., et al.. (1978). Monoamine oxidase inhibitory properties of 5-hydroxymethyl-3-m-tolyloxazolidin-2-one (toloxatone). Journal of Pharmacy and Pharmacology. 30(1). 190–192. 22 indexed citations
13.
14.
Héry, F., Guy Chouvet, J.P. Kan, Jean‐François Pujol, & J. Głowiński. (1977). Daily variations of various parameters of serotonin metabolism in the rat brain. II. Circadian variations in serum and cerebral tryptophan levels: Lack of correlation with 5-HT turnover. Brain Research. 123(1). 137–145. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuo Egawa Breakdown of academic impact, for papers by F. E. SOROKO Breakdown of academic impact, for papers by Annmarie L. Sabb Breakdown of academic impact, for papers by Richard A. Glennon Breakdown of academic impact, for papers by C Malcolm Breakdown of academic impact, for papers by Kirsten L. Miller Breakdown of academic impact, for papers by Kenneth L. Hauser Breakdown of academic impact, for papers by Hermann J. Gerhards Breakdown of academic impact, for papers by Ian T. Huscroft Breakdown of academic impact, for papers by Arvid Carlsson
Rankless by CCL
2026